鵬鼎控股(002938.SZ):擬對子公司台灣鵬鼎增資
格隆匯4月8日丨鵬鼎控股(002938.SZ)公佈,公司於2025年4月8日召開第三屆董事會第十五次會議,審議通過了《關於向全資子公司台灣鵬鼎增資的議案》:公司於2020年9月9日召開第二屆董事會第五次會議,審議通過了《關於向全資子公司增資的議案》,同意由公司向鵬鼎國際有限公司(簡稱“香港鵬鼎”)增資1億美元,再由香港鵬鼎向鵬鼎科技股份有限公司(簡稱“台灣鵬鼎”)增資新台幣30億元用於建設台灣高雄FPC項目。受相關項目建設進度對資金需求及公司資金整體調配影響,現董事會同意將相關增資事項調整為由公司全資子公司香港鵬鼎向台灣鵬鼎增資新台幣30億元(約合人民幣6.6億元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.